Recently, UPK1A-AS1 was revealed to play an oncogenic role in hepatocellular carcinoma and protect tumor cells against cisplatin toxicity by mediating the nuclear translocation of EZH2 and competing with miR-138-5p endogenously [44]. Here, EZH2 is linked to hepatocellular carcinoma.